Sign In
Buy SVA
$6.47
+0 (+0%)
At Close: Feb 07, 2020
Sinovac Announces Change of Legal Representative of Sinovac Beijing
07:44am, Monday, 28'th Aug 2023
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that the Company's subsidi
SINOVAC Reports Unaudited First Half of 2023 Financial Results
06:00am, Tuesday, 15'th Aug 2023
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial re
CoronaVac® von SINOVAC erfüllt Hongkongs Bedarf an COVID-19-Impfstoffen zur Selbstzahlung
12:22pm, Friday, 12'th May 2023
HONG KONG--(BUSINESS WIRE)--Sinovac Biotech Ltd. („SINOVAC“ oder das „Unternehmen“) (NASDAQ: SVA), ein führender Anbieter von biopharmazeutischen Produkten in China, kündete heute an, dass e
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
06:32am, Wednesday, 10'th May 2023
HONG KONG–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced it will provide its in
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
08:17pm, Monday, 01'st May 2023
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2022 annual report on Form
SINOVAC to Showcase Products at CPHI Frankfurt
07:30am, Friday, 28'th Oct 2022
Business Wire India Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company will participate in C
SINOVAC to Showcase Products at CPHI Frankfurt
05:32am, Friday, 28'th Oct 2022
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company will particip
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11, 2016 and February 22, 2019, bo
NEW YORK, Oct. 1, 2022 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11, 2016 and February 2
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
07:30am, Tuesday, 06'th Sep 2022
Business Wire India Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Chilean Public Health Institu
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
01:59am, Tuesday, 19'th Jul 2022
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that a phase III clinical tria
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
07:30am, Thursday, 14'th Jul 2022
Business Wire India Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announ...
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
05:44am, Thursday, 14'th Jul 2022
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, an...
Are These 2 Rivals Beating Pfizer and Moderna?
10:00am, Monday, 28'th Mar 2022 The Motley Fool
They're winning when it comes to orders.
Sinovac Hong Kong executive says trials for Omicron jab may start this month, global distribution in May
12:59pm, Thursday, 10'th Feb 2022 South China Morning Post
Chinese vaccine maker Sinovac Biotech has revealed that it plans to begin clinical trials for a jab to treat the highly transmissible Omicron variant this month, and hopes to begin global distribution by May.Meng Weining, vice-president of Sinovac (Hong Kong) Biotech, one of the two manufacturers supplying Covid-19 jabs to the city, said in an interview on Thursday that ongoing animal trials had shown promising results after the firm obtained Omicron samples from the local government and the
